Literature DB >> 6839815

Unimodal distribution of bronchial responsiveness to inhaled histamine in a random human population.

D W Cockcroft, B A Berscheid, K Y Murdock.   

Abstract

The population distribution of bronchial responsiveness to inhaled histamine was examined in 300 randomly selected caucasian college students (aged 20 to 29 years). Bronchial responsiveness was measured as the histamine threshold, defined as the concentration producing an FEV1 fall greater than 2 SD below the mean of five prehistamine FEV1 measurements. The cumulative prevalence of asthma was 9.3 percent, including 2.7 percent with current asthma, 3.3 percent with asthma following allergen exposure only, and 3.3 percent with remote asthma. Allergic rhinitis was present in 10.7 percent; nonallergic rhinitis in 16.3 percent; 63.7 percent had neither asthma nor rhinitis. Histamine threshold ranged from unmeasurable (greater than 8 mg/ml) in 36 percent to 0.125 mg/ml in 0.3 percent. The distribution of histamine threshold values in the responsive range was unimodal, the asthmatic subjects representing a subgroup within the hyperresponsive distribution tail rather than a separate distribution peak. Examination of the FEV1 response to 8 mg/ml showed a range between 2.8 SD increase and 100 SD reduction; the population distribution of this variable was unimodal and log normal. We concluded that there is a continuous unimodal log normal distribution of bronchial responsiveness to inhaled histamine in a random human population. Rather than representing a separate (bimodal) peak or a sharp cutoff (of a unimodal tail), the asthmatic subjects show substantial overlap with the remainder of the population.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6839815     DOI: 10.1378/chest.83.5.751

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  26 in total

Review 1.  Methodology of bronchial responsiveness.

Authors:  S Chinn
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

Review 2.  Airway hyperresponsiveness in asthma: not just a matter of airway inflammation.

Authors:  V Brusasco; E Crimi; R Pellegrino
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

3.  Comparing and combining studies of bronchial responsiveness.

Authors:  Susan Chinn
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

Review 4.  Diagnostic and therapeutic value of airway challenges in asthma.

Authors:  Donald W Cockcroft; Beth E Davis
Journal:  Curr Allergy Asthma Rep       Date:  2009-05       Impact factor: 4.806

Review 5.  Overcoming gaps in the management of asthma in older patients: new insights.

Authors:  Pranoy Barua; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 6.  Chemically induced nonspecific bronchial hyperresponsiveness.

Authors:  A Montanaro
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 7.  Epidemiology of bronchial hyperresponsiveness.

Authors:  A J Woolcock; J K Peat
Journal:  Clin Rev Allergy       Date:  1989

Review 8.  The natural history of bronchial hyperresponsiveness.

Authors:  J B Clough; S T Holgate
Journal:  Clin Rev Allergy       Date:  1989

Review 9.  Screening for asthma in children.

Authors:  A Jones
Journal:  Br J Gen Pract       Date:  1994-04       Impact factor: 5.386

Review 10.  Chronic cough. Three most common causes.

Authors:  Anthony D'Urzo; Pieter Jugovic
Journal:  Can Fam Physician       Date:  2002-08       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.